BioSpace News Archive

Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.

Inotrem S.A. announced that it has obtained authorization to launch its phase IIa clinical trial in COVID-19 patients in France, Belgium and the USA.

GO2 Foundation recognizes Professor Swanton for genetic research transforming lung cancer treatment

Innovative Patient-Centric Study Design Benefits Study Participants

Electromedical Technologies, Inc., developer and manufacturer of the WellnessPro®, an FDA cleared bioelectronic device designed to relieve chronic, intractable and acute pain, is pleased to announce an investment agreement for an aggregate $1 million investment to accelerate corporate expansion and product development.

Triplet Therapeutics, Inc., a biotechnology company leveraging insights from the human genetics of repeat expansion disorders, announced the appointment of Alan Buckler, Ph.D., as its chief scientific officer.

Partnership aims to accelerate global access to almonertinib as a treatment for individuals with non-small cell lung cancer

Evelo Biosciences, a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, announced that it will host a conference call and live webcast at 8:30 a.m.

BioCryst Pharmaceuticals, Inc. announced that the company will report its second quarter 2020 financial results on Thursday, August 6, 2020.

- Second Study Launched in Kaleido’s COVID-19 Clinical Development Program for this Rapidly Growing Patient Population -